Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Inventory Average (2016 - 2025)

China Pharma Holdings (CPHI) has disclosed Inventory Average for 15 consecutive years, with $2.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Inventory Average rose 1.94% year-over-year to $2.7 million, compared with a TTM value of $2.7 million through Sep 2025, up 1.94%, and an annual FY2024 reading of $3.1 million, down 10.01% over the prior year.
  • Inventory Average was $2.7 million for Q3 2025 at China Pharma Holdings, roughly flat from $2.7 million in the prior quarter.
  • Across five years, Inventory Average topped out at $3.8 million in Q3 2023 and bottomed at $2.4 million in Q4 2024.
  • Average Inventory Average over 5 years is $3.2 million, with a median of $3.2 million recorded in 2024.
  • The sharpest move saw Inventory Average skyrocketed 30.75% in 2023, then tumbled 37.54% in 2024.
  • Year by year, Inventory Average stood at $3.0 million in 2021, then decreased by 3.1% to $2.9 million in 2022, then soared by 30.75% to $3.8 million in 2023, then crashed by 37.54% to $2.4 million in 2024, then increased by 13.77% to $2.7 million in 2025.
  • Business Quant data shows Inventory Average for CPHI at $2.7 million in Q3 2025, $2.7 million in Q2 2025, and $2.5 million in Q1 2025.